News
StockStory.org on MSN14h
CVS Q1 Earnings Call: Guidance Raised Amid Segment Shifts and Pharmacy InnovationDiversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.
Zacks Investment Research on MSN17h
CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter 2025 results. Despite concerns over the company’s decision to implement ...
India's commercial vehicle (CV) sales aim to cross 1 million units in FY26 after two slow years. Improved freight rates, ...
Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback